Aligos Therapeutics, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Legal Proceedings
Item 1. Legal Proceedings.
We are not currently a party to any material legal proceedings. From time to time, we may be subject to various claims, lawsuits, and other legal and administrative proceedings arising in the ordinary course of business. The outcome of any such matters is inherently uncertain, and some of these matters may result in adverse judgments or awards, including penalties or injunctive relief, that could have an adverse effect on our business, financial condition, results of operations, or cash flows.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.